Pulling SEC filings + quote and writing the call…

VIEMED HEALTHCARE, INC.
Next earnings Aug 4, 2026 · consensus $0.12 EPS, $78.9M rev
Last earnings +2.3% on 2026-05-05
Revenue grew 20.5% YoY.
Middling fundamentals offset by an attractive price (~21% below fair value) — worth a look on the value angle.
Sources: SEC EDGAR (CIK 0001729149, latest 10-Q filed 2026-05-05) · EODHD · as of 6/26/2026, 6:39:12 PM.
Research and education only — not financial advice. EDGAR is not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities EDGAR rates; see Disclosures. Past performance does not guarantee future results. Do your own research.
VIEMED HEALTHCARE, INC. shows $270M in FY2025 revenue (+20.5% YoY), a 5.5% net margin, and 10.6% ROE.
The risks, catalysts, 12-month price target and the cited SEC figures behind this rating — with Pro.
Unlock with Pro€15/mo · cancel anytime
| Line item | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Revenue | $117M | $139M | $183M | $224M | $270M |
| Gross profit | $73.4M | $84.7M | $113M | $133M | $155M |
| Operating income | $11.6M | $8.25M | $14.3M | $17.9M | $22.9M |
| Net income | $9.13M | $6.22M | $10.2M | $11.3M | $14.9M |
| Diluted EPS | $0.22 | $0.16 | $0.25 | $0.28 | $0.37 |
| Net margin | 7.8% | 4.5% | 5.6% | 5.0% | 5.5% |
Annual figures from SEC 10-K XBRL filings. Open the filing links below for full statement detail.
Computed from SEC XBRL annual figures + the current quote. EV and ROIC use long-term + current debt where filed; estimates, not investment advice.
1047 tracked peers · median
Last 90 days: 0 open-market buys · 6 sales
| 2026-06-25 | Frazier William Chief Medical Officer | Exercise | 10.0K @ $1.81 | $18.1K |
| 2026-06-25 | Frazier William Chief Medical Officer | Sell | 10.0K @ $11.72 | $117K |
| 2026-06-24 | Smokoff Timothy Director | Sell | 1.64K @ $11.48 | $18.8K |
| 2026-06-24 | Smokoff Timothy Director | Sell | 3.36K @ $11.50 | $38.7K |
| 2026-06-24 | Smokoff Timothy Director | Sell | 5.00K @ $11.56 | $57.8K |
| 2026-06-24 | Smokoff Timothy Director | Sell | 5.00K @ $11.53 | $57.6K |
| 2026-06-24 | Smokoff Timothy Director | Sell | 5.00K @ $11.41 | $57.0K |
| 2026-03-20 | Moore Michael President | Sell | 65.0K @ $8.77 | $570K |
| 2026-03-19 | Moore Michael President | Sell | 40.2K @ $9.21 | $371K |
| 2026-03-18 | Moore Michael President | Sell | 31.6K @ $9.42 | $297K |
| 2026-01-29 | Hoyt Casey Chief Executive Officer | Exercise | 39.8K | |
| 2026-01-29 | Hoyt Casey Chief Executive Officer | Tax | 13.9K @ $7.48 | $104K |
Dates from 8-K (Item 2.02); beat/miss = reported EPS vs consensus (Finnhub, recent quarters); move = prior close → close on/after.
Recent news tone vs the market's typical (which skews positive). A soft signal, not a recommendation.